New Hope, PA, United States of America

Andrew J Tebben

USPTO Granted Patents = 16 

 

Average Co-Inventor Count = 4.8

ph-index = 6

Forward Citations = 140(Granted Patents)


Location History:

  • Wallingford, PA (US) (2003)
  • New Hope, PA (US) (2009 - 2019)

Company Filing History:


Years Active: 2003-2019

Loading Chart...
Loading Chart...
16 patents (USPTO):

Title: The Innovations of Andrew J Tebben

Introduction

Andrew J Tebben is a notable inventor based in New Hope, PA, with a remarkable portfolio of 16 patents. His work primarily focuses on the development of compounds that have significant implications in the treatment of inflammatory and autoimmune diseases. Tebben's contributions to the field of pharmaceuticals are noteworthy and reflect his dedication to advancing medical science.

Latest Patents

Among his latest patents, Tebben has developed tricyclic heterocyclic compounds that serve as inhibitors of TNF. These compounds are characterized by specific formulas and are designed to modulate TNFα, which is crucial in managing inflammatory responses. Additionally, he has disclosed substituted tricyclic heterocyclic compounds that also function as modulators of TNFα, further emphasizing their utility in pharmaceutical compositions aimed at treating various diseases.

Career Highlights

Tebben's career is marked by his association with Bristol-Myers Squibb Company, where he has made significant strides in pharmaceutical research and development. His innovative approach to drug design has led to the creation of compounds that are not only effective but also essential in addressing complex health issues.

Collaborations

Throughout his career, Tebben has collaborated with esteemed colleagues such as Jingwu Duan and Robert Michael Borzilleri. These partnerships have fostered an environment of innovation and have contributed to the successful development of his patented compounds.

Conclusion

Andrew J Tebben's work exemplifies the impact of innovation in the pharmaceutical industry. His patents and collaborations highlight his commitment to improving healthcare through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…